Lipoprotein(a): A missing culprit in the management of athero-thrombosis?

被引：74

作者：

Ferretti, Gianna ^{[1
]}

Bacchetti, Tiziana ^{[2
]}

Johnston, Thomas P. ^{[3
]}

Banach, Maciej ^{[4
,5
]}

Pirro, Matteo ^{[6
]}

Sahebkar, Amirhossein ^{[7
,8
]}

机构：

[1] Polytech Univ Marche, Dept Clin Sci DISCO, Marche, Italy

[2] Polytech Univ Marche, Dept Life & Environm Sci DISVA, Marche, Italy

[3] Univ Missouri, Sch Pharm, Div Pharmaceut Sci, Kansas City, MO 64110 USA

[4] Med Univ Lodz, Dept Hypertens, WAM Univ Hosp Lodz, Lodz, Poland

[5] PMMHRI, Lodz, Poland

[6] Univ Perugia, Unit Internal Med Angiol & Arteriosclerosis Dis, Dept Med, Perugia, Italy

[7] Mashhad Univ Med Sci, Biotechnol Res Ctr, Mashhad, Iran

[8] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Iran

来源：

JOURNAL OF CELLULAR PHYSIOLOGY | 2018年 / 233卷 / 04期

关键词：

apolipoprotein(a); atherosclerosis; dyslipidemia; lipoprotein(a); oxidized phospholipids; thrombosis; LOW-DENSITY-LIPOPROTEIN; TRIGLYCERIDE TRANSFER PROTEIN; HORMONE REPLACEMENT THERAPY; OXIDIZED PHOSPHOLIPIDS; CARDIOVASCULAR-DISEASE; PLASMA LIPOPROTEIN(A); FAMILIAL HYPERCHOLESTEROLEMIA; REDUCES LIPOPROTEIN(A); APOLIPOPROTEIN(A) GENE; PLASMINOGEN-ACTIVATOR;

D O I：

10.1002/jcp.26050

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Lipoprotein(a) Lp(a) is a cholesterol-rich, LDL-like particle that is independently associated with an increased risk for ischemic heart disease, atherosclerosis, thrombosis, and stroke. Genetic variation in the Lp(a) locus and some other genes related to Lp(a) synthesis and metabolism play a critical role in regulating plasma Lp(a) levels. The pathophysiological potential of Lp(a) is related to proatherogenic and prothrombotic effects on the vasculature. Different molecular mechanisms underlying the atherothrombotic potential of Lp(a), free apolipoprotein(a), and oxidized-Lp(a) have been proposed. However, plasma Lp(a) assay is complicated by problems associated with quantification and standardization owing to the polymorphic nature of this lipoprotein. This review has focused on the physicochemical properties of Lp(a), the genetic aspects of Lp(a), the need for accurate determination of Lp(a), the synthesis, and recent findings on metabolism of Lp(a). Lastly, the patho-physiological mechanisms by which Lp(a) may increase athero-thrombosis and an overview on the therapeutic modalities to interfere with Lp(a) are summarized.

引用

页码：2966 / 2981

页数：16

共 101 条

[91]

Taleb A, 2011, BIOMARK MED, V5, P673, DOI [10.2217/BMM.11.60, 10.2217/bmm.11.60]

[92] Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease [J].

Tsimikas, S ;

Brilakis, ES ;

Miller, ER ;

McConnell, JP ;

Lennon, RJ ;

Kornman, KS ;

Witztum, JL ;

Berger, PB .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (01) :46-57

[93] New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease [J].

Tsimikas, Sotirios ;

Tsironis, Loukas D. ;

Tselepis, Alexandros D. .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (10) :2094-2099

[94] A Test in Context: Lipoprotein(a) Diagnosis, Prognosis, Controversies, and Emerging Therapies [J].

Tsimikas, Sotirios .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (06) :692-711

[95] Hormonal regulation of lipoprotein(a) levels: Effects of estrogen replacement therapy on lipoprotein(a) and acute phase reactants in postmenopausal women [J].

Tuck, CH ;

Holleran, S ;

Berglund, L .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (09) :1822-1829

[96] Contribution of apolipoprotein(a) size, pentanucleotide TTTTA repeat and C/T(+93) polymorphisms of the apo(a) gene to regulation of lipoprotein(a) plasma levels in a population of young European Caucasians [J].

Valenti, K ;

Aveynier, E ;

Leauté, S ;

Laporte, F ;

Hadjian, AJ .

ATHEROSCLEROSIS, 1999, 147 (01) :17-24

[97] Long term statin treatment reduces lipoprotein(a) concentrations in heterozygous familial hypercholesterolaemia [J].

van Wissen, S ;

Smilde, TJ ;

Trip, MD ;

de Boo, T ;

Kastelein, JJP ;

Stalenhoef, AFH .

HEART, 2003, 89 (08) :893-896

[98] Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials [J].

Viney, Nicholas J. ;

van Capelleveen, Julian C. ;

Geary, Richard S. ;

Xia, Shuting ;

Tami, Joseph A. ;

Yu, Rosie Z. ;

Marcovina, Santica M. ;

Hughes, Steven G. ;

Graham, Mark J. ;

Crooke, Rosanne M. ;

Crooke, Stanley T. ;

Witztum, Joseph L. ;

Stroes, Erik S. ;

Tsimikas, Sotirios .

LANCET, 2016, 388 (10057) :2239-2253

[99] Absolute quantification of apolipoproteins and associated proteins on human plasma lipoproteins [J].

von Zychlinski, Anne ;

Williams, Michael ;

McCormick, Sally ;

Kleffmann, Torsten .

JOURNAL OF PROTEOMICS, 2014, 106 :181-190

[100] Proteomics of Lipoprotein(a) identifies a protein complement associated with response to wounding [J].

von Zychlinski, Anne ;

Kleffmann, Torsten ;

Williams, Michael J. A. ;

McCormick, Sally P. .

JOURNAL OF PROTEOMICS, 2011, 74 (12) :2881-2891

← 2 3 4 5 6 7 8 9 10 11 →